Skip to content

Onlay- vs. Inlay-Type Patellofemoral Arthroplasty: a multi-centric, retrospective, comparative study

Onlay- vs. Inlay-Type Patellofemoral Arthroplasty: a multi-centric, retrospective, comparative study - Onlay- vs. Inlay-PFA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035272
Enrollment
300
Registered
2024-10-18
Start date
2024-01-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outcome of patellofemoral prostheses in patients with isolated patellofemoral osteoarthritis

Interventions

Group 1: Patients, who received an Onlay-PFA between 2010 and 2022 Group 2: Patients, who received an Inlay-PFA between 2010 and 2022

Sponsors

Internationales Zentrum für Orthopädie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patients who received an isolated patellofemoral arthroplasty between 2010 and 2023 - Follow-up-period of at least 2 years

Exclusion criteria

Exclusion criteria: - Additional surgery on the ipsilateral knee unrelated to the patellofemoral joint Patients with concomitant patellofemoral alignment procedures (during the same anaesthesia) will not be excluded (lateral retinacular lengthening or release, rotational osteotomy around the knee, tuberosity transfer, medial patellofemoral ligament plasty).

Design outcomes

Primary

MeasureTime frame
- KOOS-Symptoms - KOOS-Pain

Secondary

MeasureTime frame
- KOOS-Activity of Daily Living - KOOS-Function, sports and recreational activities - KOOS-Qualitiy of Life - Kujala-Score - HSS-Patella-Score - Marx-Score - SF-12 Radiological outcome: - Rate of consecutive interventions / revisions - Parameters of patellofemoral tracking - Implant loosening - Progression of tibiofemoral osteoarthritis

Countries

Germany, Switzerland

Contacts

Public ContactVanessa Gross

Internationales Zentrum für Orthopädie

vanessa.gross@atos.de+49 6221 983 190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026